Xylazine is a non-opioid sedative increasingly found in the illegal drug supply—often mixed with fentanyl—raising overdose and injury risks.
HIPAA-Compliant • Same-Day Appointments • Telehealth Across Ohio
Xylazine (often called “tranq” or “tranq dope”) is a sedative used in veterinary settings and not approved for human use. It may appear in street drugs because it can intensify or prolong effects and increase product “weight” in an unregulated supply.
Why it’s especially dangerous with fentanyl and other opioids
When combined with opioids, the risk of breathing suppression increases—meaning overdose can be more severe and can last longer.
This page is educational and not a substitute for medical advice.
Withdrawal can be intense, and when multiple substances are involved, symptoms can be more complicated. Detoxing alone increases the risk of relapse and overdose.
If you’re experiencing withdrawal or escalating use, professional support can help.
One-on-one counseling
Group therapy options (if applicable)
Coping skills, trigger management, relapse prevention planning
Wound care referral pathways (if you support this)
Mental health support coordination
Post-overdose support / re-engagement
A non-opioid sedative found in some street drugs; not approved for people.
No. It’s a sedative, but it can still contribute to dangerous breathing problems.
Naloxone won’t reverse xylazine, but it can reverse opioids that are commonly mixed in—so it’s still recommended.
Call 911, continue rescue breaths, and stay with them. Additional naloxone may be needed if opioids are involved.
Xylazine exposure has been linked to severe skin wounds that can worsen and become infected.
Yes—care plans can address opioid use disorder and related health risks.
Yes—telehealth options are available statewide.
Same-day appointments may be available depending on scheduling.